top of page
Backgrounds.jpg
Statesman-Examiner Logo 2025 with Shadow.png

21 November 2025 | Colville, WA

NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

Recent Quotes

View More
Symbol Price Change (%)
AMZN  231.03
+1.36 (0.59%)
AAPL  278.63
+1.66 (0.60%)
AMD  212.34
+6.21 (3.01%)
BAC  53.06
+0.58 (1.11%)
GOOG  320.26
-3.38 (-1.04%)
META  638.07
+1.85 (0.29%)
MSFT  485.86
+8.87 (1.86%)
NVDA  180.35
+2.53 (1.42%)
ORCL  204.84
+7.81 (3.96%)
TSLA  419.59
+0.19 (0.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
bottom of page